ES2099746T3 - Metodo de deteccion y/o dosificacion de hormonas. - Google Patents

Metodo de deteccion y/o dosificacion de hormonas.

Info

Publication number
ES2099746T3
ES2099746T3 ES91910511T ES91910511T ES2099746T3 ES 2099746 T3 ES2099746 T3 ES 2099746T3 ES 91910511 T ES91910511 T ES 91910511T ES 91910511 T ES91910511 T ES 91910511T ES 2099746 T3 ES2099746 T3 ES 2099746T3
Authority
ES
Spain
Prior art keywords
pct
hormone
assay
sec
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91910511T
Other languages
English (en)
Inventor
Marie-Christine Maurel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Recherche Agronomique INRA
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Recherche Agronomique INRA filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of ES2099746T3 publication Critical patent/ES2099746T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/963—Methods of stopping an enzyme reaction or stabilizing the test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

METODO DE DETECCION Y/O DE DOSIFICACION DE LAS HORMONAS INCLUSO LAS HORMONAS PLACENTARIAS Y DE LOS ANTICUERPOS UTILIZABLES EN DICHO METODO DE DETECCION. ESTE METODO, QUE AUMENTA LA SENSIBILIDAD Y LA ESPECIFICIDAD DE LA DETECCION Y/O DE LA DOSIFICACION INMUNOLOGICA DE HORMONAS HUMANAS O ANIMALES EN MEDIOS DE CULTIVO O EN FLUIDOS BIOLOGICOS, QUE APLICA AL MENOS DOS ANTICUERPOS IDENTICOS O DIFERENTES, ESPECIFICOS DE LA HORMONA A DOSIFICAR, SE CARACTERIZA EN QUE AL MENOS UNO DE DICHOS ANTICUERPOS ESTA PREINCUBADO EN UN MEDIO QUE CONTIENE PLASMA O SUERO DESPROVISTO DE LA HORMONA A DETECTAR Y/O A DOSIFICAR (MEDIO INC)
ES91910511T 1990-06-01 1991-05-30 Metodo de deteccion y/o dosificacion de hormonas. Expired - Lifetime ES2099746T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9006863A FR2662804B1 (fr) 1990-06-01 1990-06-01 Anticorps polyclonaux anti-lh et leurs applications a la detection et/ou au dosage de la lh, chez de multiples especes animales.

Publications (1)

Publication Number Publication Date
ES2099746T3 true ES2099746T3 (es) 1997-06-01

Family

ID=9397207

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91910511T Expired - Lifetime ES2099746T3 (es) 1990-06-01 1991-05-30 Metodo de deteccion y/o dosificacion de hormonas.

Country Status (13)

Country Link
US (1) US5674700A (es)
EP (1) EP0533719B1 (es)
AT (1) ATE148562T1 (es)
AU (1) AU7958091A (es)
DE (1) DE69124511T2 (es)
DK (1) DK0533719T3 (es)
ES (1) ES2099746T3 (es)
FR (1) FR2662804B1 (es)
IE (1) IE911894A1 (es)
NZ (1) NZ238394A (es)
PT (1) PT97839B (es)
WO (1) WO1991019195A2 (es)
ZA (1) ZA914121B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3479100B2 (ja) 1993-06-02 2003-12-15 帝国臓器製薬株式会社 免疫化学的簡易半定量方法および装置
WO1998048273A1 (en) * 1997-04-23 1998-10-29 Harrison Richard J Method for fertility detection
US20010023070A1 (en) * 1998-05-29 2001-09-20 Reinhard Ebner Interleukins-21 and 22
EP1143249B1 (en) * 2000-04-03 2014-01-15 Alere Switzerland GmbH Test methods and devices for analyte isoforms
EP1143250A3 (en) * 2000-04-03 2004-11-17 Inverness Medical Switzerland GmbH Test methods and devices for analyte isoforms
JP2001349892A (ja) * 2000-04-03 2001-12-21 Unilever Nv 検査方法及びデバイス
CA2406607C (en) * 2000-04-26 2011-08-02 Land O'lakes, Inc. A method of treating soy proteins and a soy protein product produced by this method
US8592219B2 (en) * 2005-01-17 2013-11-26 Gyros Patent Ab Protecting agent
WO2006076371A2 (en) * 2005-01-10 2006-07-20 Baylor College Of Medicine Method of quantitative immunohistochemistry and in situ hybridization
EP1849004A1 (en) * 2005-01-17 2007-10-31 Gyros Patent Ab A versatile flow path
US9970897B2 (en) 2008-06-16 2018-05-15 Duke University Chemical sensors and methods for making and using the same
US9958442B2 (en) * 2009-02-11 2018-05-01 Duke University Sensors incorporating antibodies and methods of making and using the same
CN102297966A (zh) * 2011-05-27 2011-12-28 天津农学院 一种半定量检测孕酮胶体金试纸条及其制备方法
WO2013153291A1 (fr) 2012-04-12 2013-10-17 Repropharm Procede et trousse de detection du pic preovulatoire de lh
EP3107569A4 (en) 2014-02-20 2018-02-21 Alder Biopharmaceuticals, Inc. Anti-acth antibodies and use thereof
WO2015187227A2 (en) 2014-03-13 2015-12-10 Duke University Electronic platform for sensing and control of electrochemical reactions
CN105445256A (zh) * 2014-09-02 2016-03-30 江苏泽成生物技术有限公司 促黄体生成素lh定量测定试剂盒及其制备方法与检测方法
CN105424937B (zh) * 2015-10-05 2017-11-21 华中农业大学 一种猴早期妊娠检测的孕酮胶体金免疫层析试纸条
JP6959883B2 (ja) * 2018-02-28 2021-11-05 株式会社あすか製薬メディカル オキシトシンの定量方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991174A (en) * 1970-07-20 1976-11-09 Rafa Laboratories Ltd. Method of determining concentration of luteinizing hormone in body fluid
US4002532A (en) * 1974-10-21 1977-01-11 Weltman Joel K Enzyme conjugates
NO753203L (es) * 1974-11-11 1976-07-21 Carter Wallace
US4559145A (en) * 1982-06-16 1985-12-17 Amf Incorporated Process for preparing a zero standard serum
DE3225027A1 (de) * 1982-07-05 1984-01-05 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemisches messverfahren
DE3507848A1 (de) * 1985-03-06 1986-11-13 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und reagenz zur bestimmung des luteinisierenden hormons sowie hierzu geeignete monoklonale antikoerper
US4935147A (en) * 1985-12-20 1990-06-19 Syntex (U.S.A.) Inc. Particle separation method

Also Published As

Publication number Publication date
ATE148562T1 (de) 1997-02-15
DK0533719T3 (da) 1997-08-11
AU7958091A (en) 1991-12-31
ZA914121B (en) 1992-03-25
FR2662804A1 (fr) 1991-12-06
WO1991019195A2 (fr) 1991-12-12
EP0533719A1 (fr) 1993-03-31
DE69124511D1 (de) 1997-03-13
NZ238394A (en) 1993-04-28
PT97839A (pt) 1992-02-28
EP0533719B1 (fr) 1997-01-29
PT97839B (pt) 1998-10-30
DE69124511T2 (de) 1997-07-31
US5674700A (en) 1997-10-07
WO1991019195A3 (fr) 1992-01-09
FR2662804B1 (fr) 1994-05-27
IE911894A1 (en) 1991-12-04

Similar Documents

Publication Publication Date Title
ES2099746T3 (es) Metodo de deteccion y/o dosificacion de hormonas.
GB8916400D0 (en) Modified igg3
ATE185424T1 (de) Differentielle bindungsaffinitäten und darauf beruhende dissoziationstestverfahren
DE69306804T2 (de) Immunologischer test auf festphase
EP0256932A3 (en) Use of oxidase enzyme systems in chemiluminescent assays
GB2001172A (en) Competitive protein binding assay
ES2109802T3 (es) Dispositivo de ensayo y su fabricacion.
CA2130072A1 (en) Method of detecting a pathogen using a virus
ATE120550T1 (de) Verfahren zum nachweis von malignen erkrankungen.
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
EP0672062A4 (en) A PETROLEUM IMMUNE TEST METHOD, ITS COMPONENTS AND KIT FOR THEIR USE.
IT1212845B (it) Saggio immunologico utilizzante un supporto cromogeno.
FI973418A0 (fi) Vasta-ainetuotannon toteaminen
ATE114049T1 (de) Bestätigender nachweis für chlamydia trachomatis.
SE7610683L (sv) Metod for bestemning av nervaron av ett antigen associerat med hepatit
DE69521145D1 (de) Verfahren zur kompetitiven bestimmung eines haptens
DK0617790T3 (da) Diagnostisk analysesystem
KR860007545A (ko) 인체 프로릴 4-히드록시라아제의 정량 방법
TW246718B (en) Immunoassay for detecting HCV IgM antibody
ES2004066A6 (es) Metodo para analisis cualitativo y-o cuantitativo de antigenos,anticuerpos yno microorganismos u otras celulas y su correspondiente equipo
EP0379347A3 (en) Enzyme-labeled receptor composition, diagnostic kit and use in method to determine a ligand

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 533719

Country of ref document: ES